Skip to main content
Signal8

Atara Biotherapeutics, Inc. (ATRA)

Founded in 2012 and headquartered in South San Francisco, California, Atara Biotherapeutics, Inc. is dedicated to pioneering ready-to-use (off-the-shelf) T-cell immunotherapies. Their primary focus in the United States involves creating treatments for patients battling cancer, autoimmune disorders, and viral infections. A key therapeutic candidate, tabelecleucel, is currently undergoing Phase 3 clinical trials for Epstein-Barr virus (EBV)-driven post-transplant lymphoproliferative disease, as well as various hematologic and solid tumors, such as nasopharyngeal carcinoma. The company is also advancing a robust pipeline of next-generation CAR T immunotherapies designed to combat hematologic malignancies and solid tumors. This includes ATA2271 and ATA3271 targeting mesothelin, alongside ATA2431 and ATA3219 for B-cell malignancies. Furthermore, Atara is developing ATA188 for the treatment of multiple sclerosis and the ATA368 program specifically for cancers associated with human papillomavirus (HPV). To bolster its research and development efforts, Atara Biotherapeutics has established significant collaborations and licensing agreements. These include a licensing partnership with Memorial Sloan Kettering Cancer Center, a license and R&D collaboration with QIMR Berghofer Medical Research Institute, and a strategic alliance with H. Lee Moffitt Cancer Center. Additionally, the company holds a strategic partnership with Bayer AG focused on mesothelin-targeted CAR T-cell therapies for solid tumors.

Sector: Biological Products, (No Diagnostic Substances)

Industry: Biotechnology

Atara Biotherapeutics, Inc. logo

Atara Biotherapeutics, Inc.

NASDAQ:ATRAHealthcare
-6.10%$8.01
AH$8.01+0.00%vs close
Mkt Cap$81.24M
Float5.15M
O/S10.14M
Vol
$ Vol
RVOL
Inst Own44.1%
SI6.8%
Earnings
Dilution
Financials Summary
Revenue$120.77M
Net Income$32.69M
Total Assets$20.23M
Free Cash Flow-$50.94M
Debt & Equity
Debt 369%
Total Debt$52.8M
Total Equity-$38.5M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:25Reverse split
    Jun 20, 202425 shares → 1
Balance Sheet Details
Assets$20.23M
Liabilities$58.74M
Accounts Receivable$1.25M
Accounts Payable$127K
Inventory$0
PP&E (Net)$7.14M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Revenue$120.77M$128.94M$8.57M$63.57M$20.34M$0$0$0$0$0$0$0$0$0
YoY Growth-6.3%1404.0%-86.5%212.6%----------
Cost of Revenue$21.21M$21.01M$8.89M$269.99M$282M$244.65M$0$3.78M$956K$383K$48K$0$0$0
Gross Profit$99.56M$107.93M-$313K-$206.42M-$261.66M-$244.65M$0-$3.78M-$956K-$383K-$48K$0$0$0
Gross Margin82.4%83.7%-3.7%-324.7%-1286.4%---------
Research and Development$37.45M$151.48M$224.78M$272.53M$282M$244.65M$216.1M$167.46M$81.21M$56.51M$41.62M$15.45M$4.86M$9.78M
Selling, General, and Administrative$26.25M$39.89M$50.91M$68.13M$78.8M$64.4M$79.58M$69.65M$40.33M$24.73M$16.83M$12.71M$3.76M$2.5M
Other$0$0$0-$266.57M-$282M-$244.65M$0$0$0$0$0$0$0$0
Total Operating Expenses$63.7M$191.37M$275.69M$74.1M$78.8M$64.4M$295.68M$237.11M$121.53M$81.24M$58.45M$28.16M$8.62M$12.28M
Operating Income (EBIT)$35.86M-$83.44M-$276.01M-$280.51M-$340.46M-$309.05M-$295.68M-$237.11M-$121.53M-$81.24M-$58.45M-$28.16M-$8.62M-$3.23M
Operating Margin29.7%-64.7%-3219.5%-441.2%-1673.9%---------
Interest Expense$3.79M$4.62M$5.29M$373K$0$0$0$0$0$0$0$0$0$0
Interest Income$683K$2.11M$5.43M$3.06M$367K$0$0$6.37M$2.03M$2.2M$1.22M$125K$12K$0
Other Income (Expense)-$3.14M-$1.98M-$105K$52.22M$367K$2.45M$4.72M$6.37M$2.03M$2.2M$1.22M$125K$12K-$868K
Income Before Tax (EBT)$32.72M-$85.42M-$276.11M-$228.29M-$340.1M-$306.61M-$290.96M-$230.74M-$119.5M-$79.04M-$57.23M-$28.03M-$8.6M-$12.28M
Income Tax Expense$31K-$12K$15K$12K$46K$15K$12K-$44K-$14K$10K-$9K-$25K$170K$51K
Net Income$32.69M-$85.4M-$276.13M-$228.3M-$340.14M-$306.62M-$290.98M-$2.31B-$1.19B-$790.49M-$572.21M-$280.06M-$87.73M-$123.3M
Net Income Margin27.1%-66.2%-3220.9%-359.1%-1672.3%---------
Supplementary Data
EPS2.61-11.41-65.18-55.96-90.78-103.63-141.78-131.64-100.03-68.78-55.92-140.42-227.09-16.81
Diluted EPS2.57-11.41-65.18-55.96-90.78-103.63-141.78-131.64-100.03-68.78-55.92-140.42-227.09-16.81
Weighted Average OS12.54M7.49M4.24M4.08M3.75M2.96M2.05M1.75M1.19M1.15M1.02M199,44038,633733,294
EBITDA$38.63M-$75.75M-$266M-$222.26M-$330.75M-$300.72M-$288.61M-$233.38M-$120.58M-$80.86M-$58.4M-$28.15M-$8.61M-$868K
EBITDA Margin32.0%-58.7%-3102.7%-349.6%-1626.1%---------
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Assets
Current Assets
Cash and Cash Equivalents$8.48M$25.03M$25.84M$92.94M$106.08M$200.4M$74.32M$60.7M$79.22M$47.97M$23.75M$21.9M$51.62M$4.21M
Short-Term Investments$0$17.47M$25.88M$149.88M$264.98M$300.25M$184.79M$248.93M$86.87M$207.71M$296.74M$82.22M$0$0
Cash and Short-Term Investments$8.48M$42.5M$51.73M$242.82M$371.07M$500.66M$259.11M$309.63M$166.1M$255.68M$320.48M$104.12M$51.62M$4.21M
Accounts Receivable$1.25M$1.48M$34.11M$40.22M$986K$1.25M$0$0$0$0$0$0$0$0
Inventory$0$10.65M$9.71M$1.59M$0$0$0$0$0$0$0$0$0$0
Other Current Assets$2.48M$10.26M$6.33M$10.45M$194K$194K$194K$194K$194K$194K$194K$0$0$35K
Total Current Assets$12.21M$64.89M$101.87M$295.08M$384.62M$523.27M$272.99M$321.49M$172.19M$260.55M$324.6M$106.03M$51.81M$4.24M
Long-Term Assets
Property, Plant & Equipment Net$7.14M$41.1M$58.79M$74.32M$79.94M$62.82M$68.18M$68.58M$44.13M$3.26M$270K$48K$8K$9K
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$1.2M$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$886K$3.1M$4.84M$7.02M$3.57M$2.03M$1.77M$574K$1.46M$102K$108K$48K$12K$39K
Total Long-Term Assets$8.02M$44.2M$63.63M$81.34M$83.51M$64.85M$69.95M$70.35M$45.59M$3.36M$378K$96K$20K$48K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$20.23M$109.1M$165.5M$376.42M$468.13M$588.12M$342.94M$391.84M$217.78M$263.91M$324.98M$106.12M$51.83M$4.29M
Liabilities
Current Liabilities
Accounts Payable$127K$4.37M$3.68M$6.87M$17.37M$7.12M$7.96M$3.72M$14.71M$2.78M$1.45M$440K$606K$0
Short-Term Debt$10.78M$0$0$0$0$0$0$0$0$0$0$0$0$1M
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$1K$155K$0
Current Unearned Revenue$716K$95.09M$77.83M$8M$40.76M$33.45M$0-$490K$0$0$0$0$0$0
Other Current Liabilities$2.03M$6.59M$37.01M$32.75M$25.15M$19.89M$14.71M$0$500K$0$0$0$155K$241K
Total Current Liabilities$14.92M$134.57M$142.23M$78.92M$105.79M$82.9M$36.74M$39.98M$27.65M$9.68M$9.71M$2.72M$1.52M$1.3M
Long-Term Liabilities
Long-Term Debt$32.67M$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$37.56M$77M$55.71M$27.8M$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$1.79M$41.89M$39.25M$35.8M$1.5M$2.04M$1.28M$13M$12.27M$503K$166K$216K$61.32M$4K
Total Long-Term Liabilities$43.81M$71.81M$122.51M$170.86M$82.73M$42.88M$15.42M$13M$12.27M$503K$166K$216K$61.32M$4K
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0-$0
Total Liabilities$58.74M$206.38M$264.74M$249.78M$188.51M$125.78M$52.16M$52.98M$39.91M$10.18M$9.88M$2.94M$62.84M$1.31M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$61.09M$6.71M
Common Stock$1K$1K$11K$10K$9K$8K$6K$5K$3K$3K$3K$2K$1K$1K
Retained Earnings-$2.02B-$2.05B-$1.97B-$1.69B-$1.46B-$1.12B-$817.96M-$527.35M-$296.65M-$177.16M-$98.11M-$40.89M-$12.88M-$4.11M
Comprehensive Income & Other$1K$8K-$204K-$2.07M-$368K$296K$220K-$340K-$151K-$183K-$518K-$100K-$335K$0
Other Stockholders' Equity$1.98B$1.96B$1.87B$1.82B$1.74B$1.59B$1.11B$866.2M$474.51M$430.89M$413.21M$144.07M$1.86M$7.09M
Total Equity-$38.5M-$97.28M-$99.23M$126.64M$279.61M$462.34M$290.78M$338.86M$177.86M$253.74M$315.1M$103.18M-$11.02M$2.98M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$20.23M$109.1M$165.5M$376.42M$468.13M$588.12M$342.94M$391.84M$217.78M$263.91M$324.98M$106.12M$51.83M$4.29M
Supplementary Data
Total Debt$52.8M$43.83M$57.87M$71.7M$28.27M$15.03M$15.72M$738K$0$0$0$0$0$1M
Net Debt$44.32M$18.8M$32.03M-$21.24M-$77.81M-$185.38M-$58.6M-$59.96M-$79.22M-$47.97M-$23.75M-$21.9M-$51.62M-$3.2M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Operating Activities
Net Income$32.69M-$85.4M-$276.13M-$228.3M-$340.14M-$306.62M-$290.98M-$230.7M-$119.49M-$79.05M-$57.22M-$28.01M-$8.77M-$12.33M
Depreciation & Amortization$2.12M$5.05M$4.83M$5.65M$9.35M$8.33M$7.07M$3.73M$956K$383K$48K$6K$4K$3.23M
Deferred Income Tax$0$0$0$0$1.79M$958K$0-$1.89M$0$0$0$526K$0$0
Stock-Based Compensation$9.75M$27M$45.39M$53.84M$53.87M$51.35M$51.7M$33.82M$23.1M$16.78M$10.25M$10.1M$1.71M$876K
Changes in Working Capital:
  Accounts Receivable$229K$32.63M$6.11M-$39.23M$264K-$1.25M$0$0$0$0$0$0$0$0
  Inventory$10.65M-$4.43M-$8.12M-$1.59M$3.34M-$1.25M$0$0$0$0$0$0$0$0
  Accounts Payable-$4.24M$687K-$3.13M-$9.21M$9.07M-$815K$4.21M-$1.96M$2.16M$981K$1M-$164K$485K$0
  Other Working Capital-$111.38M-$59.84M$20.48M-$11.44M$39.91M$67M-$8.36M$16.96M$5.04M-$1.71M$5.18M$161K$609K$0
Total Working Capital Change-$104.73M-$30.96M$15.34M-$61.47M$52.58M$63.69M-$4.15M$15M$7.2M-$725K$6.19M-$3K$1.09M$0
Other Non-Cash Items$9.24M$15.59M$17.59M-$40.15M$2.04M$1.53M$732K$260K$732K$2.58M$3.58M$748K-$4K$5.75M
Net Cash from Operating-$50.94M-$68.72M-$192.98M-$270.43M-$220.52M-$180.76M-$235.63M-$179.77M-$87.5M-$60.02M-$37.16M-$16.63M-$5.97M-$2.48M
Investing Activities
Capital Expenditures$0-$246K-$1.22M-$4.19M-$10.58M-$4.51M-$5.73M-$35.92M-$20.23M-$3.02M-$290K-$46K-$3K-$27K
Acquisitions$948K$0$0$0-$32.84M$116.22M$0$0$0-$83.74M$0$0$0$0
Purchases of Investments-$7.88M-$19.66M-$83.65M-$180.59M-$301.13M-$425.87M-$270.23M-$466.49M-$176.46M-$304.93M-$379.78M-$95.53M$0$0
Sales of Investments$25.09M$28.54M$208.71M$292.97M$333.97M$309.65M$336.26M$306.13M$296.6M$391.69M$160.13M$12.21M$0$0
Other Investing Activities$0$0$25K$94.77M$32.84M-$116.22M$161K-$160.36M-$1.2M$83.74M-$194K-$83.32M$0$0
Net Cash from Investing$18.15M$8.62M$123.87M$202.96M$22.26M-$120.73M$60.46M-$196.29M$98.71M$83.74M-$220.13M-$83.36M-$3K-$27K
Financing Activities
Debt Repaid$250K$892K$947K$518K$254K$389K$486K$528K------
Common Stock Issuance$16.35M$59.95M$2.14M$21.89M$98.7M$422.97M$188.62M$340.88M$19.16M$0$263.43M$56.45M$0$5.04M
Common Stock Repurchases$0$0$0$0$0$0$0$0$0-$94K$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities-$1K$223K$821K$31.71M$5.5M$4.99M$655K$17.19M$892K$506K-$4.21M$337K$0$10.09M
Net Cash from Financing$16.1M$59.28M$2.01M$53.08M$103.94M$427.57M$188.79M$357.54M$20.05M$506K$259.23M$70.27M$53.38M$15.12M
Forex Effect$0$0$0$0$0$0$0$0$0$0-$94K$0$0$0
Net Change in Cash-$16.69M-$811K-$67.1M-$14.39M-$94.32M$126.09M$13.62M-$18.52M$31.25M$24.22M$1.85M-$29.72M$47.41M$12.62M
Supplementary Data
Operating Cash Flow-$50.94M-$68.72M-$192.98M-$270.43M-$220.52M-$180.76M-$235.63M-$179.77M-$87.5M-$60.02M-$37.16M-$16.63M-$5.97M-$2.48M
Capital Expenditure$0-$246K-$1.22M-$4.19M-$10.58M-$4.51M-$5.73M-$35.92M-$20.23M-$3.02M-$290K-$46K-$3K-$27K
Free Cash Flow-$50.94M-$68.96M-$194.2M-$274.62M-$231.1M-$185.27M-$241.36M-$215.7M-$107.73M-$63.05M-$37.45M-$16.67M-$5.97M-$2.5M
Cash at Beginning$25.18M$25.99M$93.09M$107.48M$201.8M$75.71M$62.09M$80.62M$47.97M$23.75M$21.9M$51.62M$4.21M$0
Cash at End$8.48M$25.18M$25.99M$93.09M$107.48M$201.8M$75.71M$62.09M$79.22M$47.97M$23.75M$21.9M$51.62M$12.62M